Woodstock

264 Million Reasons Psychedelic Stocks Have More Room to Grow

Retrieved on: 
Thursday, February 11, 2021

Finding a treatment for those 264 million people suffering from depression are what its all about.

Key Points: 
  • Finding a treatment for those 264 million people suffering from depression are what its all about.
  • OTC Stock Review introduced a large number of investors to the psychedelic sector with an article on Seeking Alpha March 6, 2020 titled " Psychedelic Medicine Stocks Capture the Attention of Investors ."
  • Almost a year later we are still focusing on psychedelic stocks and the potential treatments for depression and improving mental health.
  • MindMed also offers the broadest and most diversified pipeline of psychedelic drugs in clinical development and R&D.

Mouton Music Canada releases Thom Ryerson’s long-awaited novel, Ruby Diamond

Retrieved on: 
Thursday, February 4, 2021

Ruby Diamond A Life In The Roughfollows the career of indigenous Canadian rock n blues singer Ruby Diamond.

Key Points: 
  • Ruby Diamond A Life In The Roughfollows the career of indigenous Canadian rock n blues singer Ruby Diamond.
  • In 1969, at the age of 17, Ruby Diamond became an American sensation with her unique mix of blues driven music combined with the blood curdling rock of Janis Joplin, her heroine.
  • This is where her story really began, finding out who she really was and her true purpose on earth.
  • To purchase a print copy of Ruby Diamond A Life In The Rough, contact Thom Ryerson at [email protected]

4 Top Stocks for Huge Gains from the Psychedelic Renaissance

Retrieved on: 
Monday, January 25, 2021

Almost 11 months after that first article, it appears psychedelic stocks still have tremendous potential for explosive returns.

Key Points: 
  • Almost 11 months after that first article, it appears psychedelic stocks still have tremendous potential for explosive returns.
  • Investment banks like Canaccord Genuity Group, Eight Capital, Gravitas Securities Inc., and Mackie Research Capital Corporation are also taking an interest by raising capital for psychedelic companies.
  • MindMed (OTCQB: MMEDF) offers the broadest and most diversified pipeline of psychedelic drugs in clinical development and R&D.
  • Several psychedelic companies with deeper pockets are looking to build and acquire ketamine clincs in both the U. S. and Canada.

JSHG Announces Acquisition of the Hiltz Property

Retrieved on: 
Thursday, January 21, 2021

The Hiltz property is eight claims covering, roughly, 350 acres in The Shining Tree gold camp.

Key Points: 
  • The Hiltz property is eight claims covering, roughly, 350 acres in The Shining Tree gold camp.
  • The Company paid the prospectors three hundred thousand (300,000) JSHG common shares in return for a one hundred per cent (100%) interest in the property.
  • Gold mineralization in the area is characterized by shear or vein types characterized by a mesothermal gold mineralization model.
  • Forward looking statements are not a guarantee of future performance and results, and will not be accurate indications of the times, or by, which such performance will be achieved.

Mouton Music Canada releases Larry Mercey's long-awaited autobiography, "Have Mercey"

Retrieved on: 
Thursday, January 21, 2021

This is the definitive story of Larry Mercey as a solo artist and as a member of the Mercey Brothers.

Key Points: 
  • This is the definitive story of Larry Mercey as a solo artist and as a member of the Mercey Brothers.
  • Larry, along with his two brothers, founded the successful Canadian County Music Group, THE MERCEY BROTHERS.
  • The group dominated the airwaves from the sixties to the late eighties, winning 7 Juno Awards and gathering numerous other accolades.
  • To order a print copy of Have Mercey, contact Larry Mercey at [email protected] or call (519) 666-3994

Four Top Psychedelic Stock Picks for 2021

Retrieved on: 
Monday, January 4, 2021

With this information on psychedelic medicine in mind, here are four psychedelic stocks that could show huge returns to investors in 2021:

Key Points: 
  • With this information on psychedelic medicine in mind, here are four psychedelic stocks that could show huge returns to investors in 2021:
    MindMed (OTCQB: MMEDF) offers the broadest and most diversified pipeline of psychedelic drugs in clinical development and R&D.
  • Mycotopia Therapy specializes in evidence-based research by offering a study of an individual's psychotherapy using psychedelic medicines aided by data collection and algorithms developed with the help of psychedelic practitioners.
  • 20/20 Global will be seeking other business opportunities in the psychedelic space including psychedelic retreats and medicinal mushrooms.
  • Most of the other companies are testing the organic version of the psychedelic compound that occurs naturally in magic mushrooms.

The Next Leg in the Bull Market for Psychedelic Stocks

Retrieved on: 
Monday, December 21, 2020

As far as psychedelic stocks are concerned, most U.S. large-cap and technology stocks have growth targets priced into valuations that leave little room for shortfalls.

Key Points: 
  • As far as psychedelic stocks are concerned, most U.S. large-cap and technology stocks have growth targets priced into valuations that leave little room for shortfalls.
  • U.S. small cap stocks, which include the leading psychedelic plays, could have more upside than large cap stocks.
  • If we look at the chart pattern on any of the leading psychedelic stocks, we should see a nice series of higher highs and higher lows.
  • Most important, esketamine represents the first psychedelic treatment approved by the FDA for a psychiatric condition.

MILLER/HOWARD HIGH INCOME EQUITY FUND

Retrieved on: 
Tuesday, December 15, 2020

The Board of Trustees of the Miller/Howard High Income Fund is pleased to announce the following Officer and Trustee appointments.

Key Points: 
  • The Board of Trustees of the Miller/Howard High Income Fund is pleased to announce the following Officer and Trustee appointments.
  • Effective December 15, 2020, Lowell G. Miller has resigned from his positions as Chairman of the Board, President, and Class I Trustee of the Miller/Howard High Income Equity Fund, and has been designated as Chairman Emeritus.
  • The Board of Trustees has also elected Eva Horowitz as Secretary of the Fund, and Gregory Powell as Vice President of the Fund.
  • Miller/Howard Investments Inc. focuses on income-producing equities, with an emphasis on high-quality stocks with high yield and strong dividend growth, offering investors the opportunity for capital appreciation, current income, and growth of income.

Big-Name Executives and Celebrities Open Up Opportunities for Retail Investors by Investing in Psychedelic Treatment as a Means of Addressing Mental Health Crisis

Retrieved on: 
Tuesday, December 8, 2020

Since then, money has poured into psychedelic research and an entire new industry was created in the stock market.

Key Points: 
  • Since then, money has poured into psychedelic research and an entire new industry was created in the stock market.
  • The real money in psychedelics will be made from FDA approved drugs for the treatment of depression and mental health.
  • Investor interest in psychedelics for mental health is snowballing as many big-name executives and celebrities are investing in the sectors future.
  • Mind Medicine (MindMed) Inc. is one of the names that comes up first in discussions about psychedelic research.

Team-IIS Enters Partnership with Modus to provide Premier eDiscovery & Information Governance Services

Retrieved on: 
Thursday, November 12, 2020

Under the agreement, Team-IIS will provide technical expertise and support to Modus' eDiscovery and Information Governance services.

Key Points: 
  • Under the agreement, Team-IIS will provide technical expertise and support to Modus' eDiscovery and Information Governance services.
  • The partnership will also allow Team-IIS to become a reseller of Modus' premium suite of eDiscovery and Information Governance Solutions.
  • "We are thrilled about our partnership with Modus to provide its eDiscovery support services, and this partnership is a testimony to the progress that Team-IIS has made," said Dennis Smith, Founder & CEO of Team-IIS.
  • We are quite aware that Modus has an exceptionally high bar to its eDiscovery and Information Governance Solutions as Modus is an industry leader in these fields.